In this regard, we observed an enhancement in relative OLFM2 mRNA abundance in the SAT of NAFLD patients compared to subjects with healthy livers (Figure 3A). The gene discussed is OLFM2; the disease is metabolic dysfunction-associated steatotic liver disease.